Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $82.96
    -0.06 (-0.07%)

    Market Cap: $37.54B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GE HealthCare Technologies Inc. (GEHC) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    GE HealthCare Technologies reported revenue of $20.63B for the fiscal year ended Dec 31, 2025, up 4.8% from the year before. That year, net income was $2.15B with a net margin of 10.4%, operating cash flow was $1.99B and free cash flow was $1.50B. The quarter ended Sep 30, 2026 had revenue of $5.51B and net income of $623.00M.

    Revenue and Margins

    The operating margin was 13.4% in the fiscal year ended Dec 2025. Over the 6 years to Dec 2025, revenue grew from $16.63B, a compound annual rate of 3.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$20.63B+4.8%40.0%13.4%10.4%
    Dec 2024$19.67B+0.6%41.7%13.3%10.4%
    Dec 2023$19.55B+6.6%40.5%12.5%8.3%
    Dec 2022$18.34B+4.3%39.1%13.8%10.7%
    Dec 2021$17.59B+2.5%40.8%15.9%13.0%
    Dec 2020$17.16B+3.2%39.4%15.8%80.7%
    Dec 2019$16.63BN/A39.4%12.8%9.2%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 4.9% from the year before. In the quarter ended Sep 2026, net income rose 34.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$20.63B$19.67B$19.55B$18.34B$17.59B$17.16B$16.63B
    Cost of revenue$12.38B$11.47B$11.63B$11.16B$10.41B$10.40B$10.09B
    Gross profit$8.25B$8.21B$7.92B$7.18B$7.17B$6.77B$6.55B
    Research and development$1.26B$1.31B$1.21B$1.03B$816.00M$810.00M$833.00M
    Operating income$2.76B$2.63B$2.44B$2.52B$2.79B$2.72B$2.12B
    Net income$2.15B$2.05B$1.61B$1.97B$2.29B$13.85B$1.52B
    EBITDA$3.79B$3.67B$3.51B$3.22B$3.54B$3.41B$2.84B
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$5.51B$5.29B$5.13B$5.70B$5.14B$5.01B$4.78B$5.32B$4.86B$4.84B$4.65B$5.21B
    Gross profit$2.22B$2.18B$1.98B$2.26B$1.99B$1.99B$2.01B$2.27B$2.03B$2.00B$1.90B$2.16B
    Operating income$805.00M$739.00M$515.00M$827.00M$653.00M$654.00M$629.00M$801.00M$676.00M$608.00M$540.00M$689.00M
    Net income$623.00M$573.00M$411.00M$602.00M$464.00M$500.00M$588.00M$737.00M$490.00M$435.00M$388.00M$416.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $10.00B exceeded cash and equivalents by $5.49B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$36.91B$33.09B$32.45B$27.54B$26.31B$24.23BN/A
    Current assets$12.50B$9.90B$9.41B$8.32B$6.54B$5.45BN/A
    Cash and equivalents$4.51B$2.89B$2.50B$1.45B$556.00M$1.01BN/A
    Total liabilities$26.31B$24.44B$25.14B$17.95B$9.41B$9.25BN/A
    Short-term debt$508.00M$1.50B$1.01B$15.00M$110.00M$132.00MN/A
    Long-term debt$9.49B$7.45B$8.44B$8.23B$31.00M$31.00MN/A
    Shareholder equity$10.38B$8.45B$7.13B$9.36B$16.66B$14.73BN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$38.37B$37.25B$37.13B$36.91B$36.13B$35.50B$33.59B$33.09B$33.85B$31.85B$32.21B$32.45B
    Total liabilities$26.51B$26.03B$26.23B$26.31B$25.91B$25.55B$24.17B$24.44B$25.34B$23.86B$24.61B$25.14B
    Cash and equivalents$2.85B$2.10B$2.29B$4.51B$4.03B$3.76B$2.47B$2.89B$3.57B$2.02B$2.56B$2.50B
    Shareholder equity$11.61B$10.97B$10.67B$10.38B$9.99B$9.71B$9.19B$8.45B$8.32B$7.80B$7.41B$7.13B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 75.4% of operating cash flow. Dividends and share repurchases together came to 17.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow$1.99B$1.95B$2.10B$2.11B$1.61B$1.69B$1.99B
    Capital expenditures$482.00M$401.00M$387.00M$310.00M$248.00M$259.00M$331.00M
    Free cash flow$1.50B$1.55B$1.71B$1.80B$1.36B$1.43B$1.66B
    Dividends paid$64.00M$55.00M$41.00M$0$0N/AN/A
    Share repurchases$200.00M$0$211.00M$0$0N/AN/A
    Investing cash flow-$1.05B-$914.00M-$558.00M-$398.00M-$1.76B$19.99B-$325.00M
    Financing cash flow$617.00M-$573.00M-$478.00M-$822.00M-$263.00M-$21.54B-$1.57B
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$907.00M$168.00M$290.00M$1.05B$593.00M$94.00M$250.00M$913.00M$738.00M-$119.00M$419.00M$1.05B
    Capital expenditures$114.00M$100.00M$178.00M$134.00M$110.00M$86.00M$152.00M$102.00M$90.00M$64.00M$145.00M$94.00M
    Free cash flow$793.00M$68.00M$112.00M$916.00M$483.00M$8.00M$98.00M$811.00M$648.00M-$183.00M$274.00M$956.00M
    Last 12 quarters

    Frequently Asked Questions About GEHC

    What is GE HealthCare Technologies' annual revenue?

    GE HealthCare Technologies reported revenue of $20.63B for the fiscal year ended Dec 31, 2025.

    How fast is GE HealthCare Technologies' revenue growing?

    Revenue was up 4.8% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.0%.

    Is GE HealthCare Technologies profitable?

    Yes. GE HealthCare Technologies reported net income of $2.15B for the fiscal year ended Dec 31, 2025, with a net margin of 10.4%.

    How much free cash flow does GEHC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $1.99B minus capital expenditures of $482.00M produced free cash flow of $1.50B.

    How much debt does GE HealthCare Technologies have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $9.49B, short-term debt of $508.00M and cash and equivalents of $4.51B.